Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%, found a study published in the Journal of Clinical Oncology. The findings could lead to immediate ...
Hosted on MSN
New drug combination increases overall survival in patients with PIK3CA-mutated advanced breast cancer
Mutations in the PIK3CA gene are a key driver of breast cancer and are present in 35–40% of hormone receptor–positive breast cancers. A recently completed phase 3 clinical trial, conducted by ...
FDA grants Priority Review and assigns a PDUFA goal date of July 17, 2026MINNEAPOLIS, (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results